Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
As per available reports about 18 Conference proceedings, 4 conferences and 12 Relevant Journals are published by OMICS International relevant to Coronary Artery bypass Grafting.
Coronary Artery Bypass Grafting is defined as open-heart Surgery in which a section of a blood vessel is grafted from the aorta to the coronary artery to bypass the blocked section of the coronary artery and improve the Blood supply to the heart. By the state-of-the-art techniques developed in Bypass Surgery, the Cardiovascular Diseases and Case Reports on Pathology can be restudied for the newest approaches towards Coronary Artery bypass Grafting.
Scope & Importance
Coronary artery bypass graft surgery is a procedure used to treat coronary artery disease in certain circumstances. Coronary artery disease is the narrowing of the coronary arteries, caused by a build-up of fatty material within the walls of the arteries. This build-up causes the inside of the arteries to become contracted, restraining the supply of oxygen-rich blood to the heart muscle. While the traditional "open heart" procedure is still done and often preferred in many situations, newer, less hostile techniques have been advanced to bypass blocked coronary arteries. "Off-pump" procedures, in which the heart does not have to be stopped, were advanced in the 1990's. Other minimally-invasive procedures, such as key-hole surgery and robotic procedures, progressively are being used. Traditional approaches involve making long surgical incisions down the inner thigh and/or calf. Research comparing traditional approaches with endoscopic methods shows that patients generally have less complication, reduced amount of leg pain, and shorter hospital stays with the endoscopic harvesting methods. Some persons, however, may not be suitable for these methods because of other health situations.
The patho physiology of coronary artery disease was established in 1876 by Adam Hammer when he postulated that angina (imbalance of coronary perfusion supply and demand) was caused by interruption of coronary blood supply and that myocardial infarction occurred after the occlusion of at least one coronary artery.
In the 19th century heart Surgery was performed infrequently and with poor results. In 1896, Stephen Paget wrote that “surgery of the heart has probably reached the limits set by nature to all surgery”. In that same year, Ludwig Rehn successfully conducted heart surgery repairing a stab wound. In 1910, Alexis Carrel was the first to describe CABG. The development of the heart-lung machine ushered in the era of modern cardiac Surgery. Coronary artery bypass graft surgery (CABG) remains the most common operation performed by cardiac surgeons today. From its infancy in the 1950s till today, CABG has undergone many developments both technically and clinically. Improvements in intraoperative technique and perioperative care have led to CABG being offered to a more broad patient profile with less complications and adverse events.
Our review outlines the rich history and promising future of myocardial revascularization.Around 10 National symposiums and conferences are going to be held across the globe which includes “13th Holistic Approaches In Cardiovascular Diseases Symposium 2014 (HOPECARDIS 2014)”, “The 14th Annual International Symposium on Congenital Heart Disease” and “31st Annual Symposium Cardiology for the Practitioner” and many more. Some of the Heart disease associations are the European Society of Cardiology , exists primarily to reduce the burden of cardiovascular disease in Europe. The European Atherosclerosis Society (EAS) goal is to provide a framework for concerted scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis. The National Heart and Lung Institute, its main aim is to carry out research, development and education in cardiovascular and respiratory science.
CABG is the most common type of open-heart surgery in the United States. Doctors called cardiothoracic surgeons do this surgery. However, CABG isn't the only treatment for CHD. Other treatment options include lifestyle changes, medicines, and a procedure called coronary angioplasty.
Angioplasty is a non-surgical procedure that opens blocked or narrow coronary arteries. During angioplasty, a stent might be placed in a coronary artery to help keep it open. A stent is a small mesh tube that supports the inner artery wall.CABG or angioplasty may be options if you have severe blockages in your large coronary arteries, especially if your heart's pumping action has already grown weak. CABG also may be an option if you have blockages in the heart that can't be treated with angioplasty. In this situation, CABG may work better than other types of treatment.
The goals of CABG may include:
-Improving your quality of life and reducing angina and other CHD symptoms.
-Allowing you to resume a more active lifestyle.
-Improving the pumping action of your heart if it has been damaged by a heart attack.
-Lowering the risk of a heart attack (in some patients, such as those who have diabetes).
-Improving your chance of survival.
Decline in isolated coronary artery bypass graft (CABG) procedures in the United States and Europe will mainly be credited to the increasing use of percutaneous coronary intervention (PCI), which is less invasive and offers shorter recovery times. In specific, younger patients or patients with less severe coronary artery disease are progressively being referred for PCIs. The average age of patients undertaking CABG procedures is therefore growing, and these patients are more likely to suffer from other heart-related diseases that will also oblige treatment. As a result, the proportion of CABG surgeries done at the same time as other procedures, such as open surgical heart valve procedures or surgical ablations, will increase, which helps to sustain overall CABG procedure volumes through 2021. In the US and Europe, there will be a slender increase in revenues for devices used in endoscopic vessel harvesting (EVH) because they are less invasive when compared to traditional vessel harvesting methods.
OMICS International organises 1000+ Global Events every Year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
• World Heart Failure Society
• American Heart Association
• Canadian Cardiovascular Society Heart Failure
• Heart Rhythm Society
• Association of Women Surgeons
• Atlanta Heart Associates Pc
• Heart Failure Society of America
• Society of Invasive Cardiovascular Professionals
• American Association of Heart Failure Nurses
• Association of American Medical Colleges
• American Medical Association
• American Society for Artificial Internal Organs
• American Society of Extra-Corporeal Technology
• American Society of Transplant Surgeons
• American Thoracic Society
• Association for Academic Surgery
• Canadian Association of Thoracic Surgeons
• Congenital Heart Surgeons' Society
• Federation of State Medical Boards of the United States
• General Thoracic Surgery Club
• Heart Failure Society of America
• Heart Valve Society of America
• Perfusion Program Directors' Council
• Philippine Heart Association
Related Companies and hospitals
• AUM Cardiovascular
• Cerevast Therapeutics
• Paragon Medical
• Apaxis Medical
• Paragon Medical
• Angel Medical Systems
• Topera Medical
• Lombard Medical Technologies Plc
• AtriCure, Inc.
• Sorin S.p.A.
• SurModics, Inc.
• Cook Medical Incorporated
• Genzyme Corporation
• GE Healthcare
• Abiomed, Inc.
• Osiris Therapeutics, Inc.
• Boston Scientific Corporation
• CryoLife, Inc.
• Philips Healthcare
• Mesoblast the regenerative medicine company
This page will be updated regularly.
This page was last updated on 14th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising